An exploratory biomarker analysis included a four-gene gene expression signature (CD8A, STAT1, LAG3, and CD27), TMB (tumor mutation burden), and the pulmonary immune prognostic index (LIPI) measured according to LDH levels and neutrophil/lymphocyte ratios (NLR) in peripheral blood [29]. This evidence concerns the gene CD8A and neoplasm.